Literature DB >> 7596313

Protective immunity to the group A Streptococcus may be only strain specific.

S A de Malmanche1, D R Martin.   

Abstract

M protein enables Group A streptococci to resist phagocytosis. Protective immunity is considered to be mediated by opsonic antibodies directed against this M protein. In recent studies we have shown that genetically distinct populations exist within an M-type. The question asked in this study was whether human and rabbit type specific M1 antibody was opsonic for all strains of M-type 1, irrespective of their restriction fragment length polymorphism type. When locating a blood donor from among our staff for use in the indirect bactericidal test, selective variation in opsonic ability was demonstrated by one person. Subsequent testing of 44 randomly selected human sera revealed that 11 (25%) had opsonic antibody. Of these 11, 6 opsonised all seven strains and 5 demonstrated selective opsonisation. We conclude that opsonic antibody is not necessarily type specific but may be strain specific.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7596313     DOI: 10.1007/BF00196680

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  Identification of sequence types among the M-nontypeable group A streptococci.

Authors:  W A Relf; D R Martin; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

3.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein.

Authors:  M Rýc; E H Beachey; E Whitnack
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Streptococcal M protein: an antiphagocytic molecule assembled on the cell wall.

Authors:  V A Fischetti; E C Gotschlich; G Siviglia; J B Zabriskie
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

6.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Streptococci--are they different in New Zealand?

Authors:  D R Martin; G E Meekin; L A Finch
Journal:  N Z Med J       Date:  1983-04-27

8.  Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein.

Authors:  M P Harbaugh; A Podbielski; S Hügl; P P Cleary
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

9.  Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.

Authors:  E Whitnack; E H Beachey
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.

Authors:  G H STOLLERMAN; F S KANTOR; B D GORDON
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

View more
  11 in total

1.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolates.

Authors:  Claudia M Brandt; Gerhard Haase; Barbara Spellerberg; Regina Holland; Rudolf Lütticken
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes.

Authors:  James B Dale; Thomas Penfound; Edna Y Chiang; Valerie Long; Stanford T Shulman; Bernard Beall
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

4.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.

Authors:  H Basma; A Norrby-Teglund; Y Guedez; A McGeer; D E Low; O El-Ahmedy; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Authors:  Stephen B Beres; Gail L Sylva; Daniel E Sturdevant; Chanel N Granville; Mengyao Liu; Stacy M Ricklefs; Adeline R Whitney; Larye D Parkins; Nancy P Hoe; Gerald J Adams; Donald E Low; Frank R DeLeo; Allison McGeer; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

6.  Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia.

Authors:  D L Gardiner; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

7.  Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase.

Authors:  B A Leonard; M Woischnik; A Podbielski
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 8.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

9.  Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.

Authors:  Patrick R Shea; Amy L Ewbank; Javier H Gonzalez-Lugo; Alexandro J Martagon-Rosado; Juan C Martinez-Gutierrez; Hina A Rehman; Monica Serrano-Gonzalez; Nahuel Fittipaldi; Stephen B Beres; Anthony R Flores; Donald E Low; Barbara M Willey; James M Musser
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

10.  emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway.

Authors:  B R Kittang; S Skrede; N Langeland; C G Haanshuus; H Mylvaganam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-20       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.